DOCSLIB.ORG

NIHAA Update Is the Newsletter Ofthe Stanford University, and Now Editor of Many of the Agency's Manufacturing NIH Alumniassociation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
NIHAA Update Is the Newsletter Ofthe Stanford University, and Now Editor of Many of the Agency's Manufacturing NIH Alumniassociation The Newsletter of the NIH Alumni Association Summer 2002 Vol. 14, No. 2 date Zerhouni Selected 15th Briefings on Bioterrorism, Award Presentation to NIH Director Fredrickson at 2002 NIHAA Annual Meeting By Rich McManus The reality of the nation's concern with terrorism was brought home to Dr. Elias Zerhouni (pronounced eh­ those who attended NlHAA's annual LEE-as zer-800-nee) was confirmed, meeting on June 1. The principal pro­ by unanimous voice vote of the U.S. gram presentation was an authoritative Senate on May 2, to become 15th ctirec­ briefing on bioterrorism, and t11e venue tor of the National Institutes of Health. of the meeting itself was in part deter­ Two days earlier, at a 75-minute confir­ mined by anti-terrorism measures. The mation hearing before the Senate com­ Cloister, site of previous meetings, is mittee on health, education, labor, and within the NIH secu1ity perimeter. Its pensions chaired by Sen.Ted Kennedy use for the Saturday session was not (which also voted unanimously to con­ feasible. However, the nearby fllm), Zerhouni offered a preliminary vi­ Bethesda United Methodist Church sion of his µJans for NIH, which in­ provided a welcome and comfortable clude relying not only on the creative meeting hall with parking for about 7~ spark of the individual scientist, but members and guests who attended the also on a "new science" approach em­ meeting. Dr. Donald S. Fredrickson- 11th NIH Director phasizing multidisciplinary teams work­ ing in concert. (See Annual Meeting, p. 11) A successful administrator, entrepre­ neur, basic scientist and clinician him­ Zerhouni Welcomed, Kirschstein Applauded at self during more tban a guarter century 84th ACD Meeting on June 6 at Johns Hopkins University School of Medicine, Zerhouni, who appeared By Carla Garnett with his mother, bis wife Nadia and three children, as well as with a friend Just moments after 8:30 a.m. on June 6 business executives that assembles on (See Zerhowii, p.12) and a scant 2 weeks after his first day campus to consider the NIH enterprise on the job,new NIH director Dr. Elias every June and December. Zerhouni was formally handed the (See ACD, p. 14) gavel at the 84'11 meeting of the advi­ sory committee to the director (ACD), In This Issue Page which he now chairs as head of the Dr. Donald Kennedy to deliver sixth 2 agency. James A. Shannon lecture "I think we should have a ceremony Research Festival 2002 schedule 3 that allows Dr. Zerhouni's previous Calendar of exhibits and events 5 home institution to tum the gavel over News from and about NIHAA members 6 to our new chairman," said NIH deputy director Dr. Ruth Kirschstein, who had Safra Founda1ion supports family lodge J 6 chaired the twice-yearly ACD meetings NlH haven from antinepotism rules 18 as acting NIH director since 2000. She Bioterrorism at NJl:I 20 calledonA CD member Dr. William FYI 22 Brody, president of Johns Hopkins Uni­ NIH notes 24 versity, to introduce Zerhouni to the Dr. Donald S. Fredrickson (1924-2002) 30 Dr. Elias Zerhouni · 15th NIH Director 36-year-old gathering of physicians, re­ NIH retrospective 31 searchers, lawyers, professors and N I H A A U P D A T E Dr. Donald Kennedy To Give Sixth Shannon Lecture On Wednesday, Nov. 20, 2002, Dr. Drug and Cosmetics Act i:n the pro­ Donald Kennedy, foaner FDA commis­ posed Drug Regulation Reform Act of Update sioner (1977-1979), former president of 1978, and conducted amajorrevision of The NIHAA Update is the newsletter ofthe Stanford University, and now editor of many of the agency's manufacturing NIH AlumniAssociation. The NIHAA office is Science magazine, will deliver the sixth practices. He left in June 1979 and re­ at 9101 Old Georgetown Rd., Bethesda, MD James A. Shannon Lecture at 3 p.m. in turned to Stanford, where he was vice 20814-1616, 301-530-0567; email address: Masur Auditorium, Bldg. 10. He will president for academic affairs and pro­ [email protected]; we/Jsile: wwwfnih. speak on "A Second Postwar Revolu­ vost and then, from 1980 to 1991, presi­ org!nihaa. .htm l. tion in Biomedicine." dent of the university. Editor's Note Kennedy is an intemationally recognized In 1992, Kennedy returned to the neurophysiologist who was born in New Stanford faculty as Bing professor of en­ The ND-IAA Update welcomes letters and Yorlcin 1931. He pursued both his under­ vironmental sciences. He was named in news from its re(J.(/ers. We wish to provide graduate and graduate education at Harvard June 2000 editor of Science. The many news about NIH to its alumni and to report alumni concerns and informatio~ppoint­ receiving a Ph.D. inbiological sciences in recognitions he has received include hon­ ments, honors, publications and other interest­ 1956. Following a 4-yearpeiiod on thefac­ orary degrees from Columbia, Rochester, ing developments--10 their colleagues. If you ulty of Syracuse University, he moved in Michigan and Arizona universitie.c; and have news about yourself or other alumni or 1960 to thedepaitment ofbiological sci­ membership in the National Academy of comments/suggestions for the N1HAA Up­ ences at Stanford, the institution where he Sciences. date, please drop a note to the editor. We has spent the restof bis academic career. In 1997, the NIHAA established a reserve the right to edit materia_ls. His broad interests include comparative lecture series named in honor of Dr. Editor: Harriet R. Greenwald mruine biology, public policy, nutrition and James A. Shannon, NIH director recombinant DNA technology. He was ap­ from 1955 to 1968, to promote public NIHAA Newsletter EditorialAdyisory pointed to head FDA in April 1977. discussion of issues that affect the Committee As FDA commisioner, he dealt with mission of intramural and extramural Storm Whaley, Chair , the ban on saccharin, the overhauling NIH. The event is supported by the Artrice Bader of the drug provisions of the Federal NTH Federal Credit Union. Michael M. Gottesman Victoria A. Harden Carl Leventhal Mark your calendar Robert G. Martin Abner L. Notkins Saul Rosen THIS IS YOURJNVITATIONTO THE SHANNON LECTURE Richard G. Wyatt The NIB Alumni Association NTHAA Newsletter Board of Contributing cordially invites you to attend the sixlh Editors James A. Shannon Lecture PamelaE. Anderson Linda Brown "A Second Postwar Revolution in Giorgio Bernardi Biomedicine" H. Franklin Bunn Henryk Eisenberg Dr. Donald Kennedy Lars A. Hanson Wednesday, Nov. 20, 2002 at 3 p.m. George Klein Richard M. Krause Masur Auditorium, Bldg. 10 Richard McManus Carlos Monge Roger Monier Michael Sela 2 SUMMER 2 0 0 2 NIHAA Officers Cyrus R, Creveling, President Research Festival '02 Slated for Oct. 15-18 Murray Goldstein, Vice.President Carolyn McHale, Vice President By Paula Cohen J. Paul Van Nevel, SeG-retary/1reasurer Preparations are well under way for these representatives. For a listing of Past Presidents the 16'hann ual NIH Research Festival exhibitors and more information, visit William I Gay, 1999- 2002 to be held on the Bethesda campus tl1e NIH Job Fair web site at William S. Jordan, Jr., 1997-1999 on Oct. 15-18. The festival organizing www.training.nih.gov/jobfair. CalvinB. Baldwin,Jr., 1995-1997 committee, co-chaired this year by Dr. Two days of scientific symposia be­ Thomas J . Kennedy, Jr., 1993-1995 Barry Hoffer, scientific director, gin with plenary session 1 on Wednes­ .Joe R. Held, 1991-1993 Gordon D. Wallace, 1990-1991 NIDA, and Dr. Thomas Kindt, direc­ day morning, Oct 16 from 8:30 - 10:30 tor, Division oflntramural Research, a.m. on "Biode.fense: A New NIH Board ofDirectors NIAID, has planned a wide-ranging Mission," is chaired by Dr. Thomas Alexander Adler program showcasing the scientific di­ Kindt, NIAID. Plenary session 2, Artrice V. Bader versity of the intramural research pro­ "Bench-to-Bedside: NIH Success Sto­ W. Emmet/. Barkley gram. ries," chaired by Dr. Barry J. Hoffer, Edwin Becker This year 's festival will follow a for­ NIDA, will be Thursday, Oct. 17 from William Branche, Jr. Samuel Broder mat similar to last year's, with two ple­ 8:30 - 10:30 a.m. Both plenary sessions Christine Carrico nary sessions, 12 mini-symposia, and will be held in Natcher Center-Audito­ Andrew Chiarodo four poster sessions; a job fair for rium. Rita Colwell postdoctoral fellows; a biomedical re­ The morning plenary sessions will be Julius Currie search equipment show; special exhib­ followed by concurre~t mini-symposia Murray Eden Joan Fredericks its on intramural resources; and several with topics solicited from the 1C scien­ Carl Fretts lunchtime food fairs as well as other re­ tific directors and members of the vaii­ Samuel S. Herman freshments served throughout the day ous special .interest groups. Four Margaret Heydrick (for details, see box on p. 4). poster sessions are also scheduled, fea­ Jane SundelofJones The NTH Job Fair for postdoctu.ral turing poster presentations by NIH .in­ l!win Kopin John Landon fellows, sponsored by the Foundation tramural scientists. L. Earl Laurence for the NIH and spearheaded by the The Technical Sales Association Carl Leventhal NIH Office ofEducation's acting direc­ will again sponsor the popular re­ Terry L. Lierman tor Brenda Hanning and fair coordina­ search festival exhibit show on Thurs­ Sally Nichols tor Shirley Forehand, will kick off re­ day and Friday, Oct. 17 and 18. Over .lames O'Donnell Vincent Oliverio search festival events on Tuesday, 400 exhibit booths will display state­ Karl Piez Oct.15. A keynote address on "From of-the-art equipment, supplies, and Richard Sherberl NIH Bench to the Biotech Bedside," services by leading regional and na­ Lawrence £.
Load more

Recommended publications
  • Sanofi-Aventis Press Release
    Sanofi-aventis press release Sanofi-aventis appoints Dr. Elias Zerhouni, President, Global Research & Development Paris, France - December 14, 2010 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) is pleased to announce the appointment of Dr. Elias Zerhouni as President, Global Research & Development, covering Medicines and Vaccines, effective January 1, 2011. Dr. Zerhouni will report directly to Christopher A. Viehbacher, Chief Executive Officer of sanofi-aventis, and join the Executive Committee and the Management Committee. Marc Cluzel, M.D., Ph.D., will resign as Executive Vice President, R&D but will continue to work closely with Elias as a scientific expert. “I would like to sincerely thank Marc for his long term contribution. His passion for science and commitment thus far has ensured a readiness to lead the implementation of the transformation of R&D over the past few years,” said Christopher A. Viehbacher, Chief Executive Officer of sanofi-aventis. Since his appointment as Scientific Advisor to Christopher Viehbacher in February 2009, Dr. Zerhouni has been instrumental in redesigning the R&D model to foster increased innovation, the first pillar of the Group’s strategy. The effect of this transformation has already delivered results with a reinvigorated R&D that will provide innovative solutions in response to specific, unmet needs of patients. Centered on the patient, the development of scientific networks and openness to the external scientific world has strengthened the creativity and the flexibility of the company and brought a truly entrepreneurial approach to research. “I have had the privilege of working with Elias for a long time. Through his vast experience and visionary approach, he has provided excellent advice and insight and has been central in implementing what is now one of the most promising R&D models in healthcare,” said Christopher A.
    [Show full text]
  • Eulogy for the Clinical Research Center
    Eulogy for the clinical research center David G. Nathan, David M. Nathan J Clin Invest. 2016;126(7):2388-2391. https://doi.org/10.1172/JCI88381. Op-Ed The extramural General Clinical Research Center (GCRC) program has been funded for more than 50 years, first by the National Center for Research Resources, NIH, and more recently as part of the Clinical Translational Science Award (CTSA) program through the newly formed National Center for Advancing Translation Sciences (NCATS). The GCRCs represent the federally funded laboratories that employ a highly trained cadre of research nurses, dietitians, and other support staff and in which generations of clinical investigators trained and performed groundbreaking human studies that advanced medical science and improved clinical care. Without the opportunity for adequate discussion, NCATS has now stopped funding these Research Centers. In this “eulogy,” we review the origins and history of the GCRCs, their contributions to the advancement of medicine, and the recent events that have essentially defunded them. We mourn their loss. Find the latest version: https://jci.me/88381/pdf OP-ED The Journal of Clinical Investigation Eulogy for the clinical research center David G. Nathan1 and David M. Nathan2 1Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. 2Diabetes Center and Clinical Research Center, Massachusetts General Hospital (MGH), Harvard Medical School, Boston, Massachusetts, USA. icans with a desire to learn the biomedical research technology of the early twentieth The extramural General Clinical Research Center (GCRC) program has been century were forced to travel to England, funded for more than 50 years, first by the National Center for Research France, Austria, or Germany.
    [Show full text]
  • Leading History Elias A. Zerhouni, MD December 19, 2019
    Episode 16: Leading History Elias A. Zerhouni, MD December 19, 2019 American College of Radiology, through its Radiology Leadership Institute (RLI), offers this podcast as one of a series of educational discussions with radiology leaders. The podcasts reflect the perspectives of the individual leaders, not of ACR or RLI. ACR disclaims liability for any acts or omissions that occur based on these discussions. Listeners may download the transcript for their own learning and share with their colleagues in their practices and departments. However, they may not copy and redistribute any portion of the podcast content for any commercial purpose. Episode 16: Leading History Elias A. Zerhouni, MD [00:00:01.282] Geoff: This month, we have an extra special holiday treat for you. As you will soon hear, Elias Zerhouni has had profoundly broad influence both within the field of radiology and well beyond it through the establishment of national policies for the organization and prioritization of health sciences research, advising international heads of state on science and technology strategy, facilitating the global availability of vaccines, and reorganizing one of the world's largest pharmaceutical companies to pivot from small molecule discovery to the development of therapeutic biologics. Elias Zerhouni has fearlessly approached his career as a series of professional disruptions that offer a lesson to us all in taking chances and making bold decisions. [00:00:51.453] No matter where you are in your career, as you listen to Elias's story, I invite you to reflect on your own journey and the decisions that you may be facing.
    [Show full text]
  • Interview with Dr. James Wyngaarden (JW) Jennifer Midura (JM), Center for Public Genomics, Institute for Genome Sciences & Policy, Duke University December 8, 2006
    Interview with Dr. James Wyngaarden (JW) Jennifer Midura (JM), Center for Public Genomics, Institute for Genome Sciences & Policy, Duke University December 8, 2006 JM: The information I am about to give you and your response will now be recorded. My name is Jennifer Midura and I am a student at Duke University. I am in a course on the history of genomics that includes oral history. One goal is to produce a written transcript of interviews with important figures in genomics. Some of the interviews may be archived or made public through a website. I selected you as the person I would like to interview. The interview should last about 45 minutes. Your participation in this interview is strictly voluntary, and you may withdraw at any time. You do not have to answer every question asked. The information that you provide will be “on the record” and may be attributed to you. This interview is being recorded and I will take written notes during the interview. The interviews that are posted publicly will be archived as a history resource. If you prefer that the interview be used only for the course and not made public, please indicate this. One risk of this study is that you may disclose information that later could be requested for legal proceedings. Or you may say something that embarrasses you or offends someone else when they read it on a public website. The benefit of participating in this study is ensuring that your side of the story is properly portrayed in the history of genomics.
    [Show full text]
  • Tyears the News Media Have Been Awash in Storie'abljut Increasingly Close Ties Between O College Campuses and Multimillion-Dollar Corpora­ - Tions
    :,1 C/) In recentyears the news media have been awash in storie'abljut increasingly close ties between o college campuses and multimillion-dollar corpora­ - tions. Our nation's universities, the story goes, reap m enormtus windfalls patenting products of scientific z ****************** ***~1* research that have been primarily funded by taxpay­ ers. Meanwhile, hoping for new streams of revenue SC IENCE SA{E from their innovations, the same universities are o j FOR allowing their research-and their very principles­ m to become compromised by quests for profit. But "Tl is that really the case? Is money really hopelessly o corrupting science? ;0 With Science for Sale, acclaimed journalist Daniel REliI\A~RmS, S. Greenberg reveals that campus capitalism is more ,THE PER I LS, complicated-and less profitable-than media reports C/) would suggest. While universities seek out corporate ",'AND DELUS IIQti;' '" \ funding, news stories rarely note that those industry » ~US ~ dollars are dwarfed by government support and r ·tfti/... ITA!..! s.M other funds. Also, while many universities have set up m technology-transfer offices to pursue profits through patents, many of those offices have been financial **;~:*.** busts. Meanwhile, science is showing signs of provid-: **'. ,. -: . :",,":);::,:!,:::,,:/..<':-:' ', **t*.' '::,:J<;," ****** ***.'*' * ing its own solutions, as highly publicized misdeeds in pursuit of profits have provoked promising counter­ measures within the field. But just because the threat is overhyped, Greenberg argues, doesn't mean that there's no danger. From research that's shifted overseas so corporations can avoid regulations to conflicts of interest in scientific I publishing, the temptations of money will always be I a threat, and they can only be countered through the viqilance of scientists, the press, and the public.
    [Show full text]
  • October 28, 2003, NIH Record, Vol. LV, No. 22
    R a StillThe SecondPayday BestThingAbout Hill Hearing Airs NIH Needs, Telework on the Rise Congress' Concerns By Rich McMenus Top Reasons More AreChoosing On the heels of the debut of NIH's new More NIH'ers Opt To Work Awayfrom Work To Work from Roadmap initiative and release of an Home Institute of Medicine report on the structure and vitality of NIH, a hearing was held Oct. t's not as if anyone needs added incentive to roll.out of bed a 2 at which director Dr. Elias Zerhouni ZerhouniLaunches little later, spend a few extra minutes with the family, steer reported to joint Senate and House Roadmap Initiative clear of rush-hour traffic or accomplish a day's work virtually uninterrupted.I No, the reason that committees on how closely the two visions merge as NIH faces its post-budget­ telework is growing-but still only doubling future. The directoralso heard a slowly-could be that few employees 'Director's Corner' realize the option may be available host of lawmakers' concerns, ranging from Speaks to NIH'ers A-76 to stem cells to studiesof human to them. However, as campus sexuality. parking spaces become rarer this fall, more people may be seeking-and NAS' Alberts To Zerhouni was joined at the witnesstable by more managers and supervisors Speak, Nov. 3 his predecessor, Dr. Harold Varmus, and by encouraging-ways to work away Dr. Harold Shapiro, who chaired the IOM from work. The trend is picking up committee on NIH revitalization; all three Cultural Lecture speed at NIH and throughout government.
    [Show full text]
  • Debt Ceiling Negotiations Come Down to the Wire
    PAGE 5 PAGE 6 INSERT Report: U.S. Lagging in Stem Cell Lawsuit The Role of the CDC in University R&D Dismissed Global Health R&D JULY-AUGUST 2011 ReTHEsearch ADVOCATE BRINGING RESEARCH CLOSER TO HOME Debt Ceiling Negotiations Come Down to the Wire At the time of this writing, debt ceiling tus to cut funding for health research these caps would limit the amount by negotiations between the White House and all discretionary programs has which agency budgets are able to grow. and congressional leadership have never been greater and it is up to you The National Institutes of Health stalled. Recent proposals for raising to turn the tide. budget, for example, is currently about the debt ceiling have included manda- If an agreement is reached, it could $31 billion for this fiscal year. A long- tory long-term spending cuts and result in deep cuts in funding for term spending cap would hamstring spending caps. Everyone in the health health research and long-term restric- funding for health research at NIH and research community needs to step up tions on any potential future increases other agencies. their advocacy efforts now. The impe- in discretionary spending. Ultimately, Continued on page 4 One Mind Forum Lays Out Plan the anniversary of tors and create partnerships toward the for Neuroscience Research former President goal of a greater understanding of brain John F. Kennedy’s disorders. The group hopes to raise an The One Mind for Research Forum, 1961 challenge to send a man to the additional $1.5 billion for brain held in Boston and featuring world- moon within a decade.
    [Show full text]
  • The Future of Genomic Medicine VI Conference
    Scripps Translational Science Institute In Partnership with AAAS/Science Translational Medicine Present The Future of Genomic Medicine VI Conference Scripps Seaside Forum ‐ Scripps Institution of Oceanography Robert Paine Scripps Forum for Science, Society and the Environment Samuel H. Scripps Auditorium La Jolla, California Thursday March 7th 2013 Friday March 8th 2013 Conference Faculty David Altschuler, MD, PhD Investigator of the Howard Hughes Medical Institute Professor of Genetics & Medicine, Harvard Medical School Professor of Genome Sciences Center for Human Genetic Research University of Washington Department of Molecular Biology Seattle, Washington Diabetes Unit, Department of Medicine Massachusetts General Hospital Jonathan Eisen, PhD Richard B. Simches Research Center Professor Director, Program in Medical and Population Genetics UC Davis Genome Center Broad Institute of Harvard and MIT Department of Evolution and Ecology, College of Biological Sciences Russ B. Altman, MD, PhD Department of Microbiology and Immunology, Associate Professor of Genetics and of Medicine School of Medicine Stanford University Davis, California Stanford, California David B. Goldstein, PhD Katrina Armstrong, MD, MSCE Director, Center for Human Genome Variation Professor of Medicine The Richard and Pat Johnson Distinguished University of Pennsylvania School of Medicine University Professor Philadelphia, Pennsylvania Duke Center for Human Genomic Variation Durham, North Carolina Mark T. Bertolini Chairman, Chief Executive Officer and President Jerome Groopman, MD Aetna Dina and Raphael Recanati Professor of Medicine, Harvard Medical School Cinnamon S. Bloss, PhD Chief of Experimental Medicine, Assistant Professor Beth Israel Deaconess Medical Center Scripps Translational Science Institute, Scripps Health & The Scripps Research Institute Susan Desmond Hellman, MD, MPh La Jolla, California Chancellor University of California, San Francisco Atul Butte, MD, PhD San Francisco, California Associate Professor, Pediatrics – Systems Medicine Stanford School of Medicine A.J.
    [Show full text]
  • Re-Engineering Clinical Research Hearing
    NIH: RE-ENGINEERING CLINICAL RESEARCH HEARING BEFORE THE SUBCOMMITTEE ON HEALTH OF THE COMMITTEE ON ENERGY AND COMMERCE HOUSE OF REPRESENTATIVES ONE HUNDRED EIGHTH CONGRESS SECOND SESSION MARCH 25, 2004 Serial No. 108–69 Printed for the use of the Committee on Energy and Commerce ( Available via the World Wide Web: http://www.access.gpo.gov/congress/house U.S. GOVERNMENT PRINTING OFFICE 93–301PDF WASHINGTON : 2004 For sale by the Superintendent of Documents, U.S. Government Printing Office Internet: bookstore.gpo.gov Phone: toll free (866) 512–1800; DC area (202) 512–1800 Fax: (202) 512–2250 Mail: Stop SSOP, Washington, DC 20402–0001 VerDate 11-MAY-2000 12:01 Apr 28, 2004 Jkt 000000 PO 00000 Frm 00001 Fmt 5011 Sfmt 5011 93301.TXT HCOM1 PsN: HCOM1 COMMITTEE ON ENERGY AND COMMERCE JOE BARTON, Texas, Chairman W.J. ‘‘BILLY’’ TAUZIN, Louisiana JOHN D. DINGELL, Michigan RALPH M. HALL, Texas Ranking Member MICHAEL BILIRAKIS, Florida HENRY A. WAXMAN, California FRED UPTON, Michigan EDWARD J. MARKEY, Massachusetts CLIFF STEARNS, Florida RICK BOUCHER, Virginia PAUL E. GILLMOR, Ohio EDOLPHUS TOWNS, New York JAMES C. GREENWOOD, Pennsylvania FRANK PALLONE, Jr., New Jersey CHRISTOPHER COX, California SHERROD BROWN, Ohio NATHAN DEAL, Georgia BART GORDON, Tennessee RICHARD BURR, North Carolina PETER DEUTSCH, Florida ED WHITFIELD, Kentucky BOBBY L. RUSH, Illinois CHARLIE NORWOOD, Georgia ANNA G. ESHOO, California BARBARA CUBIN, Wyoming BART STUPAK, Michigan JOHN SHIMKUS, Illinois ELIOT L. ENGEL, New York HEATHER WILSON, New Mexico ALBERT R. WYNN, Maryland JOHN B. SHADEGG, Arizona GENE GREEN, Texas CHARLES W. ‘‘CHIP’’ PICKERING, KAREN MCCARTHY, Missouri Mississippi, Vice Chairman TED STRICKLAND, Ohio VITO FOSSELLA, New York DIANA DEGETTE, Colorado STEVE BUYER, Indiana LOIS CAPPS, California GEORGE RADANOVICH, California MICHAEL F.
    [Show full text]
  • What People Are Saying About
    What People Are Saying about Key Quotes from Influencers Out of the Shadows dinner. the Trish and George team. Trish was dedicated e no for an Senator Roy Blunt (R-MO), Chairman, Subcommittee on the Departments of Labor, Health and Human Services, Education, and Related Agencies, Senate Committee on Appropriations Senator Patty Murray (D- Senator Susan Collins (R-ME), Co- they will be able to stop it in its Senator Amy Klobuchar (D- it should be bipartisan, it should be non-partisan, and it should be all of America, all hands on deck, all out to find the cure! Trish and George both they are insistent, they are persistent, and they are really a turbo team when it comes to Former Senator Barbara Mikulski (D-MD) national goal of 2025 if it weren't for George and Trish. We have greater resources devoted to preventing and treating the disease and an u Melody Barnes, former Director, White House Domestic Policy Council; Founding Member, many do in a life-long career. A lot of people have created organizations. George and Trish have created a nati Elias Zerhouni, MD, President, Global R&D, Sanofi; former Director, National Institutes of Health on many issues. Even among such leaders, George and Trish Vradenburg stand out for what they have from skeptical policymakers to exhausted caregivers to frustrated scientists n doing so, they have Diane Rehm, Host, On My Mind podcast; former Host/Executive Producer, The Diane Rehm Show (NPR); Member, WomenAgainstAlzh NO ONE is better positioned to make history than you, and I want to be right there when ve been easy and fair for George and Trish to rest on their laurels and enjoy a leisurely retirement.
    [Show full text]
  • October 6, 2006, NIH Record, Vol. LVIII, No. 20
    OCTOBER 6, 2006 The Second Best Thing About Payday VOL. LVIII, NO. 20 People Get Ready NIH Team Races to Prepare for Pandemic Flu By Belle Waring ABOVE · Pictures can be worth a thousand words in conveying health messages. See IH is developing a continuity of operations plan (COOP) for pandemic avian story below. N influenza (bird flu). The effort is being led by Dr. Pierre Noel, assisted by a team features of 10 working groups. The goal is to maintain critical operations and protect patients, visitors and employees, as well as animals and ongoing work. 1 “We need a critical number of employees to maintain operations [in the event Bird Flu Plan for Employees Takes Shape of an emergency],” Noel says. “A lot of people ask, ‘What if panflu does not occur?’ The answer is: We are working through a process that will apply to any emergency 3 on campus. Even if panflu never occurs, we will still be much better off because of ‘Energy Month’ Offers Ways to Save this effort.” 5 Chief of hematology in the Clinical Center’s department of laboratory medicine, Poster Day Honors NIA Retiree Noel was appointed last winter as pandemic flu COOP coordinator (seeNIH Record, Hughes Mar. 10, 2006). An Air Force Special Operations Command flight surgeon and an ad- 12 visor on weapons of mass destruction, disaster planning and biodefense, Noel also New ‘Captain’ Joins NIGMS recently accepted a detail as acting associate director for security and emergency see pandemic flu, page 8 departments Images Boost Health Extraordinary ‘Literacy’ Is the Norm for Bu Explores Use of Director’s Pioneers Briefs 2 Posters in Chinese Training 10 Public Health How can NIH help Milestones 11 By Belle Waring extraordinarily inno- vative scientists Say you have a pub- explore ideas that lic health problem have the potential whose scale is vast: for unusually high a population of 500 impact? One way million, with 90 per- is through the NIH cent living in the In 1965, a massive public Director’s Pioneer 2005 Pioneer Award countryside, where health campaign used posters Award program, part recipient Dr.
    [Show full text]
  • Elias Zerhouni, M.D. Professor Emeritus, Johns Hopkins University
    Elias Zerhouni, M.D. Professor Emeritus, Johns Hopkins University Elias Zerhouni, M.D., Professor Emeritus Radiology and Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA. Dr. Zerhouni was most recently the President, Global Research & Development, and a member of the Executive Committee for Sanofi from January 2011 to July 2018. Dr. Zerhouni’s academic career was spent at the Johns Hopkins University and Hospital where he was professor of Radiology and Biomedical engineering and senior adviser for Johns Hopkins Medicine. He served as Chair of the Russell H. Morgan Department of Radiology and Radiological Sciences, Vice Dean for Research and Executive Vice Dean of the School of Medicine from 1996 to 2002 before his appointment as Director of the National Institutes of Health from 2002 to 2008. In that position he oversaw the NIH’s 27 Institutes and Centers with more than 18,000 employees and a budget of $29.5 billion (2008). In November 2009, President Obama appointed Dr. Zerhouni as one of the first presidential U.S. science envoys. Dr. Zerhouni also served as senior fellow to the Bill and Melinda Gates foundation from 2009 to 2010 and senior advisor to the CEO of Sanofi. Dr. Zerhouni has founded or co-founded five start-up companies, authored more than 200 publications and holds several patents. He has assumed positions on several Boards, including most recently, the board of the Lasker Foundation, Research!America and the NIH Foundation. He is also a member of the U.S. National Academy of Medicine and the U.S. National Academy of Engineering.
    [Show full text]